Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
The Vanguard Group reported a 7.16% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 7.16% stake in Syndax Pharmaceuticals, Inc., 6,230,334 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 7.16%
- Shares
- 6,230,334
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 7.16% | 6,230,334 |
Source
Related
- Syndax Pharmaceuticals, Inc.
- The Vanguard Group
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026